Hepatitis Monthly

Published by: Kowsar

A Single Center Study Comparing the Stainable Iron Depositions in 1000 Explanted Cirrhotic Livers of Different Causes

Bita Geramizadeh 1 , 2 , * , Yalda Ghazanfari 2 , Saman Nikeghbalian 3 and Seyed-Ali Malekhosseini 3
Authors Information
1 Department of Pathology, Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Department of Pathology, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Surgery, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: December 01, 2015, 15 (12); e33710
  • Published Online: December 28, 2015
  • Article Type: Research Article
  • Received: October 9, 2015
  • Revised: November 23, 2015
  • Accepted: November 28, 2015
  • DOI: 10.5812/hepatmon.33710

To Cite: Geramizadeh B, Ghazanfari Y, Nikeghbalian S, Malekhosseini S. A Single Center Study Comparing the Stainable Iron Depositions in 1000 Explanted Cirrhotic Livers of Different Causes, Hepat Mon. 2015 ; 15(12):e33710. doi: 10.5812/hepatmon.33710.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Abu Rajab M, Guerin L, Lee P, Brown KE. Iron overload secondary to cirrhosis: a mimic of hereditary haemochromatosis? Histopathology. 2014; 65(4): 561-9[DOI][PubMed]
  • 2. Stuart KA, Fletcher LM, Clouston AD, Lynch SV, Purdie DM, Kerlin P, et al. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. Hepatology. 2000; 32(6): 1200-7[DOI][PubMed]
  • 3. Jaskiewicz K, Banach L, Lancaster E. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population. Anticancer Res. 1997; 17(5B): 3897-9[PubMed]
  • 4. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 1997; 112(3): 882-8[PubMed]
  • 5. Deugnier Y, Turlin B, le Quilleuc D, Moirand R, Loreal O, Messner M, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol. 1997; 21(6): 669-75[PubMed]
  • 6. Parolin MB, Batts KP, Wiesner RH, Bernstein PS, Zinsmeister AR, Harmsen WS, et al. Liver allograft iron accumulation in patients with and without pretransplantation hepatic hemosiderosis. Liver Transpl. 2002; 8(4): 331-9[DOI][PubMed]
  • 7. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol. 1998; 29(2): 257-62[PubMed]
  • 8. Batts KP. Iron overload syndromes and the liver. Mod Pathol. 2007; 20 Suppl 1-9[DOI][PubMed]
  • 9. Sebastiani G, Tempesta D, Alberti A. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. J Viral Hepat. 2012; 19(2)-6[DOI][PubMed]
  • 10. Lin D, Ding J, Liu JY, He YF, Dai Z, Chen CZ, et al. Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis. PLoS One. 2013; 8(6)[DOI][PubMed]
  • 11. Lin TJ, Liao LY, Lin SY, Lin CL, Chang TA. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C. World J Gastroenterol. 2006; 12(30): 4897-901[PubMed]
  • 12. Lambrecht RW, Sterling RK, Naishadham D, Stoddard AM, Rogers T, Morishima C, et al. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology. 2011; 140(5): 1490-500 e3[DOI][PubMed]
  • 13. An IC, Tiwari AK, Ameda S, Laird-Fick HS. Autoimmune hepatitis: diagnostic dilemma in the setting of suspected iron overload. Case Rep Gastrointest Med. 2013; 2013: 872987[DOI][PubMed]
  • 14. Dostalikova-Cimburova M, Kratka K, Stransky J, Putova I, Cieslarova B, Horak J. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases. Dis Markers. 2012; 32(1): 65-72[DOI][PubMed]
  • 15. Iqbal T, Diab A, Ward DG, Brookes MJ, Tselepis C, Murray J, et al. Is iron overload in alcohol-related cirrhosis mediated by hepcidin? World J Gastroenterol. 2009; 15(46): 5864-6[PubMed]
  • 16. Aigner E, Weiss G, Datz C. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World J Hepatol. 2015; 7(2): 177-88[DOI][PubMed]
  • 17. Huang YH, Yu-Hsieh H, Huang CC, Shin-Mu VT, Tai MH, Chen CL, et al. Liver hepcidin and stainable iron expression in biliary atresia. Pediatr Res. 2006; 59(5): 662-6[DOI][PubMed]
  • 18. Jain S, Agarwal S, Tamhankar P, Verma P, Choudhuri G. Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population. Indian J Gastroenterol. 2011; 30(4): 161-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments